Compare Tenet Healthcare Corporation (THC) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Tesla, Inc. — how do they compare? Tenet Healthcare Corporation trades at $264.68 (market cap $20.86B), while Tesla, Inc. trades at $371.71 (market cap $1.45T). The key difference: Tesla, Inc. is far larger — about 69.5× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals.
| THC | TSLA | |
|---|---|---|
Market Cap | $20.86B | $1.45T |
Sector | Health | Consumer Cyclical |
52-Week High | $280.77 | $489.88 |
52-Week Low | $161.37 | $298.16 |
Enterprise Value | $31.94B | $1.43T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.06, down 2.26% today, with a neutral technical signal despite bullish moving averages. The company demonstrates strong profitability with 82.83% gross margins and 53.31% ROE, while trading at attractive valuations with a 10.25 P/E ratio. Recent earnings have consistently beaten expectations, and analysts maintain strong buy sentiment with an $281.44 price target. The company recently announced a $1.5 billion debt refinancing to optimize its capital structure.
THC presents a compelling investment case with strong fundamentals and analyst support, though investors should monitor debt management and healthcare regulatory risks. The stock offers value with upside potential to analyst targets, supported by consistent earnings outperformance and improving profit margins projected for 2026.
Tesla (TSLA) trades at $371.77, up 5.0% on the day, with a bullish technical signal from moving averages and support at $359. Recent earnings show a Q2 2026 miss but beats in prior quarters. Revenue declined to $94.83B in 2025, with net income margin at 3.67%. The stock faces high valuation multiples, including a P/E of 340.89. News highlights regulatory approval for self-driving software in Europe (Reuters, 2026-04-10) and a surge in German registrations (Zacks, 2026-04-10).
Outlook is mixed: bullish technicals and analyst consensus ($398.38 target) support upside, but high valuation and competitive pressures in EVs pose risks. Growth depends on execution in autonomy and energy segments, with investor sentiment cautious amid delivery misses and shifting business focus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
